AtlasBenignOral Lipoma

Benign Tumors

Oral Lipoma

Benign tumour of mature adipocytes; the commonest mesenchymal soft-tissue neoplasm but comparatively rare in the oral cavity.

Tissue
Mature adipocytes
Rx
Excision
Recurrence
Rare

§ overviewOverview

Benign neoplasm composed of mature adipose tissue enclosed by a thin fibrous capsule.

§ icdICD Classification

D17

§ epidemiologyEpidemiology

Oral lipoma <5% of head-neck lipomas; adults 40–60 y; buccal mucosa most common.

§ clinicalClinical Features

  • 01Soft, yellow, dome-shaped, freely mobile submucosal mass
  • 02Painless, slow-growing
  • 03Positive 'slip sign'

§ differentialDifferential Diagnosis

  • 01Mucocele
  • 02Fibroma
  • 03Salivary gland tumour
  • 04Dermoid cyst

§ histopathHistopathology

  • 01Lobules of mature adipocytes with peripheral nuclei separated by fibrous septa; thin capsule

§ investigationsInvestigations

  • 01Clinical diagnosis usually; USG or MRI for deep lesions (fat-signal hyperintense on T1)

§ classificationClassification

  • 01Classical lipoma
  • 02Fibrolipoma
  • 03Angiolipoma
  • 04Spindle-cell lipoma
  • 05Pleomorphic lipoma
  • 06Intramuscular lipoma

§ treatmentTreatment

  • 01Conservative surgical excision with capsule — curative

§ complicationsComplications

  • 01Recurrence very rare after complete excision

§ prognosisPrognosis

Excellent; malignant transformation to liposarcoma exceedingly rare (except atypical lipomatous variants).

§ examKey Examination Points

  • 01Slip sign, yellow hue transilluminates
  • 02MRI shows fat signal

§ revisionQuick Revision Summary

  • 01Adipocyte tumour · buccal mucosa · excision curative

§ vivaBDS Viva Questions

  • 01Slip sign?
  • 02MRI fat signal?
  • 03Variants of lipoma?

§ mcqsMCQs — Assessment (3)

Question 1

Commonest oral site:

Question 2

Treatment:

Question 3

MRI signal on T1:

References

  1. Neville BW. Oral & Maxillofacial Pathology, 4e

Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.